Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
185 studies found for:    "gastrointestinal stromal tumor"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
"gastrointestinal stromal tumor"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)
Conditions: Gastrointestinal Stromal Tumors;   KIT +;   Resected Gastrointestinal Stromal Tumors;   Non-metastatic;   High Risk of Recurrence
Intervention: Drug: Imatinib maintenance
2 Completed Gastrointestinal Stromal Tumors (GIST) Registry
Condition: Gastrointestinal Stromal Tumors
Intervention: Other: GIST Registry
3 Completed Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting
Condition: Gastrointestinal Stromal Tumors
Intervention:
4 Unknown † Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001
Condition: Gastrointestinal Stromal Tumor
Interventions: Genetic: mutation analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis
5 Recruiting A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: Famitinib
6 Active, not recruiting Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: dasatinib
7 Terminated Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Drug: sunitinib malate;   Other: pharmacological study
8 Completed S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: temozolomide
9 Completed Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Procedure: conventional surgery
10 Completed Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Nilotinib
11 Unknown † Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor
Conditions: Gastrointestinal Stromal Tumor;   Metastatic Cancer
Intervention: Procedure: therapeutic conventional surgery
12 Completed Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: Nilotinib
13 Completed Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Glivec
14 Unknown † Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor
Conditions: Gastrointestinal Stromal Tumor;   Metastatic Cancer
Intervention: Drug: imatinib mesylate
15 Completed Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: AMN107, STI571
16 Terminated
Has Results 		Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients
Conditions: Gastrointestinal Stromal Tumors,;   Cancer,;   Solid Tumors
Interventions: Drug: Peginterferon-alpha 2b (PegIFNa2b);;   Drug: Imatinib
17 Completed Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Imatinib Mesylate
18 Completed Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
19 Terminated Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Procedure: therapeutic conventional surgery
20 Active, not recruiting Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: imatinib mesylate
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years